Cogent Biosciences, Inc. (COGT) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 10 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for COGT is $48.13, representing a +31.9% upside from the current price of $36.49. Price targets range from a low of $35.00 to a high of $60.00.
